HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gierada, D. S. Articles by Bae, K. T. Search for Related Content PubMed PubMed Citation Articles by Gierada, D. S. Articles by Bae, K. T.

Gadolinium as a CT Contrast Agent: Assessment in a Porcine Model

¹ Mallinckrodt Institute of Radiology, Washington University School of Medicine, Barnes-Jewish Hospital, 216 S Kingshighway Blvd, St Louis, MO 63110.

PURPOSE: To investigate the use of gadolinium as a computed tomographic (CT) contrast agent.

MATERIALS AND METHODS: In vitro attenuation measurements of multiple dilutions of gadodiamide and ioversol were compared. In three pigs, 50-mL boluses of undiluted gadodiamide were injected intravenously at 2 mL/sec, and repeated single-level scans were obtained through the lung bases, liver, and kidneys. The doses of 0.8–1.0 mmol of gadolinium per kilogram of body weight were approximately three times the highest doses currently used in patients. Enhancement was determined from attenuation measurements in the aorta, pulmonary arteries, liver, and kidneys.

RESULTS: In vitro, the attenuation of undiluted gadodiamide (3,069 HU) was equivalent to that of ioversol diluted to 106 mg of iodine per milliliter and at equimolar concentrations was 50% greater than that of ioversol. The magnitude of and time to peak enhancement were 141 HU and 27 seconds (n = 3) for the aorta; 168 HU and 21 seconds (n = 3) for the pulmonary arteries; 23 HU and 65 seconds (n = 2) for the liver; and 63 HU and 32 seconds (n = 1) for the kidneys. Time-attenuation curves revealed a useful duration of enhancement of 20–30 seconds for the aorta and pulmonary arteries.

CONCLUSION: Gadolinium produces good vascular enhancement, adequate renal enhancement, and suboptimal hepatic enhancement. Further study is needed to determine the safety of the gadolinium dose required to produce similar enhancement in patients.

Index terms: Computed tomography (CT), contrast enhancement, 60.12112, 60.12116, 761.12112, 761.12116, 81.12112, 81.12116 • Computed tomography (CT), contrast media, 60.12112, 60.12116, 761.12112, 761.12116, 81.12112, 81.12116 • Contrast media, experimental studies • Gadolinium

This article has been cited by other articles:

				C. Chicoskie and R. Tello Gadolinium-Enhanced MDCT Angiography of the Abdomen: Feasibility and Limitations Am. J. Roentgenol., June 1, 2005; 184(6): 1821 - 1828. [Abstract] [Full Text] [PDF]

				M. Remy-Jardin, P. Dequiedt, O. Ertzbischoff, I. Tillie-Leblond, J. Bruzzi, A. Duhamel, and J. Remy Safety and Effectiveness of Gadolinium-enhanced Multi-Detector Row Spiral CT Angiography of the Chest: Preliminary Results in 37 Patients with Contraindications to Iodinated Contrast Agents Radiology, June 1, 2005; 235(3): 819 - 826. [Abstract] [Full Text] [PDF]

				J. W. Henson, R. G. Nogueira, D. J. Covarrubias, R. G. Gonzalez, and M. H. Lev Gadolinium-Enhanced CT Angiography of the Circle of Willis and Neck AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 969 - 972. [Abstract] [Full Text] [PDF]

				U. Nyman, B. Elmstahl, P. Leander, M. Nilsson, K. Golman, and T. Almen Are Gadolinium-based Contrast Media Really Safer than Iodinated Media for Digital Subtraction Angiography in Patients with Azotemia? Radiology, May 1, 2002; 223(2): 311 - 318. [Abstract] [Full Text] [PDF]